Indoline derivatives substituted in position 6, production and use thereof as medicaments

Details for Australian Patent Application No. 2010202845 (hide)

International Classifications

Event Publications

22 July 2010 Application Open to Public Inspection

Published as AU-A-2010202845

22 July 2010 Complete Application Filed

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

17 March 2011 Section 223 Application Received

Boehringer Ingelheim Pharma GmbH & Co. KG An application to extend the time from 22 Jul 2010 to 22 Feb 2011 in which to pay a continuation fee has been filed . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

12 May 2011 Section 223 Application Allowed

Boehringer Ingelheim Pharma GmbH & Co. KG The time in which to pay a continuation fee has been extended to 22 Feb 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application was refused. Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.